ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy.

Wan-Ru Chao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.